Michael Raab

Insider profile

Currently holds positions in Amicus Therapeutics Inc and Ardelyx Inc

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
32 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Lead Independent Director Amicus Therapeutics Inc Sept. 7, 2018 -
President, Chief Executive Officer, Director Ardelyx Inc March 1, 2009 -
Independent Director Amicus Therapeutics Inc Jan. 1, 2004 - Sept. 7, 2018

Michael Raab's trades of Ardelyx Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-17 2026-07-15 PlS Planned sale
1,819 -11.5%
331.40
US$2,472,797
1,819 -11.5% 331.40 US$2,472,797
2026-06-17 2026-06-15 PlS Planned sale
49,600 -49.5%
468.06
US$3,853,756
49,600 -49.5% 468.06 US$3,853,756
2026-06-17 2026-06-15 PrS Proposed sale
3,321
321.26
US$2,192,703
3,321 321.26 US$2,192,703
2026-06-15 2026-06-15 PrS Proposed sale
125,000
5.69
US$711,250
125,000 5.69 US$711,250
2026-05-22 2026-05-21 S Sale
14,028 -0.8%
6.27
US$87,920
14,028 -0.8% 6.27 US$87,920
2026-05-22 2026-05-21 S Sale
17,926 -1.0%
6.27
US$112,351
17,926 -1.0% 6.27 US$112,351
2026-05-22 2026-05-21 S Sale
7,861 -0.4%
6.27
US$49,269
7,861 -0.4% 6.27 US$49,269
2026-05-22 2026-05-21 S Sale
14,933 -0.8%
6.27
US$93,593
14,933 -0.8% 6.27 US$93,593
2026-05-19 2026-05-19 PrS Proposed sale
44,500
6.23
US$277,235
44,500 6.23 US$277,235
2026-05-19 2026-05-15 PlS Planned sale
41,666 -2.3%
6.28
US$261,612
41,666 -2.3% 6.28 US$261,612
2026-04-17 2026-04-15 PlS Planned sale
41,668 -2.3%
6.29
US$261,954
41,668 -2.3% 6.29 US$261,954
2026-03-18 2026-03-16 PlS Planned sale
41,666 -2.2%
5.84
US$243,329
41,666 -2.2% 5.84 US$243,329
2026-02-25 2026-02-24 PlS Planned sale
41,666 -2.2%
6.26
US$260,621
41,666 -2.2% 6.26 US$260,621
2026-02-24 2026-02-24 PrS Proposed sale
166,666
5.75
US$958,330
166,666 5.75 US$958,330
2026-02-23 2026-02-20 S Sale
2 -0.0%
5.70
US$11
2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
1 -0.0%
5.70
US$6
1 -0.0% 5.70 US$6
2026-02-23 2026-02-20 S Sale
2 -0.0%
5.70
US$11
2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
5,576 -0.3%
5.71
US$31,860
5,576 -0.3% 5.71 US$31,860
2026-02-23 2026-02-20 S Sale
40,401 -2.1%
5.87
US$236,952
40,401 -2.1% 5.87 US$236,952
2026-02-20 2026-02-20 PrS Proposed sale
51,100
5.73
US$292,803
51,100 5.73 US$292,803
2025-11-25 2025-11-21 S Sale
46,887 -3.1%
5.54
US$259,609
46,887 -3.1% 5.54 US$259,609
2025-11-20 2025-11-20 PrS Proposed sale
45,868
5.91
US$271,080
45,868 5.91 US$271,080
2025-08-25 2025-08-21 S Sale
45,687 -3.0%
5.93
US$271,002
45,687 -3.0% 5.93 US$271,002
2025-05-22 2025-05-20 S Sale
46,817 -2.9%
4.08
US$191,079
46,817 -2.9% 4.08 US$191,079
2025-05-05 2025-05-02 S Sale
41,666 -2.5%
4.25
US$177,168
41,666 -2.5% 4.25 US$177,168
2025-05-02 2025-05-02 PrS Proposed sale
125,000
5.47
US$683,750
125,000 5.47 US$683,750
2025-04-08 2025-04-04 PlS Planned sale
41,666 -2.5%
4.59
US$191,151
41,666 -2.5% 4.59 US$191,151
2025-03-07 2025-03-07 PlS Planned sale
41,668 -2.5%
5.36
US$223,199
41,668 -2.5% 5.36 US$223,199
2025-02-21 2025-02-20 S Sale
22,964 -2.1%
5.62
US$129,124
22,964 -2.1% 5.62 US$129,124
2025-01-31 2025-01-31 PlS Planned sale
41,666 -3.6%
5.36
US$223,355
41,666 -3.6% 5.36 US$223,355
2025-01-10 2025-01-07 S Sale
41,666 -3.6%
5.31
US$221,309
41,666 -3.6% 5.31 US$221,309
2025-01-07 2025-01-07 PrS Proposed sale
166,666
5.00
US$833,330
166,666 5.00 US$833,330
2024-12-12 2024-12-10 PlS Planned sale
25,000 -2.1%
5.26
US$131,620
25,000 -2.1% 5.26 US$131,620
2024-12-10 2024-12-10 PrS Proposed sale
25,000
5.26
US$131,618
25,000 5.26 US$131,618
2024-11-27 2024-11-25 PlS Planned sale
25,000 -2.1%
5.38
US$134,482
25,000 -2.1% 5.38 US$134,482
2024-11-25 2024-11-25 PrS Proposed sale
25,000
5.38
US$134,480
25,000 5.38 US$134,480
2024-11-22 2024-11-20 S Sale
31,980 -2.6%
4.79
US$153,328
31,980 -2.6% 4.79 US$153,328
2024-11-12 2024-11-11 PrS Proposed sale
2,743
4.90
US$13,441
2,743 4.90 US$13,441
2024-11-12 2024-11-11 PlS Planned sale
2,743 -0.2%
4.90
US$13,441
2,743 -0.2% 4.90 US$13,441
2024-10-31 2024-10-28 PlS Planned sale
25,000 -2.0%
5.91
US$147,740
25,000 -2.0% 5.91 US$147,740
2024-10-28 2024-10-28 PrS Proposed sale
25,000
5.91
US$147,740
25,000 5.91 US$147,740
2024-10-15 2024-10-11 PlS Planned sale
7,500 -0.6%
6.01
US$45,075
7,500 -0.6% 6.01 US$45,075
2024-10-11 2024-10-11 PrS Proposed sale
7,500
6.01
US$45,075
7,500 6.01 US$45,075
2024-09-27 2024-09-26 PlS Planned sale
3,000 -0.2%
6.07
US$18,210
3,000 -0.2% 6.07 US$18,210
2024-09-26 2024-09-26 PrS Proposed sale
3,000
6.07
US$18,210
3,000 6.07 US$18,210